FDA drug approvals, clinical trials, and progressive medical treatments.
A massive study of nearly 1 million people reveals that spouses of dementia patients face a significantly higher risk of developing the condition themselves.
The WHO has issued updated guidelines for dementia prevention, emphasizing lifestyle changes while cautioning against reliance on certain supplements.
Escalating violence in dementia care facilities raises alarms as staffing shortages and poor safety protocols lead to tragic resident-on-resident fatalities.
New research from the U.K. Biobank reveals that metabolic syndrome significantly accelerates brain aging, offering potential pathways for preventative care.
Explore the latest medical advancements, from declining U.S. hospital infection rates to improved diagnostic algorithms for pulmonary embolism in cancer patients.
A new study reveals that cumulative physiologic stress, measured through salivary cortisol, is a significant predictor of faster cognitive decline in older adults.
New research shows Alzheimer's blood tests boost primary care diagnostic accuracy to 88%, helping doctors make better clinical decisions for patients.
Recent data from Utah and South Carolina reveal alarming rates of encephalitis and sepsis in unvaccinated measles patients. Read the latest health findings.
A new study reveals that while hypoglossal nerve stimulation for sleep apnea offers long-term heart benefits, it carries unexpected early-stage cardiovascular risks.
A breakthrough blood test measuring p-tau217 levels can predict Alzheimer's-related cognitive decline up to 10 years early, offering new hope for prevention.
A phase II trial reveals that a specific THC-CBD combination significantly reduces agitation in hospice-eligible dementia patients, offering new hope for care.
New phase II clinical trial results for diranersen reveal promising cognitive benefits and tau reduction in early-stage Alzheimer's disease patients.